Omeprazole in Pregnancy: Safety, Risks & Clinical Guidance

Omeprazole, a proton‑pump inhibitor (PPI), treats gastroesophageal reflux disease (GERD), peptic ulcers, and hypersecretory conditions. Current evidence suggests it is generally safe during pregnancy, but a nuanced risk‑benefit assessment is essential.

Safety Data

  • Large cohort studies and meta‑analyses show no significant increase in major congenital malformations with first‑trimester PPI exposure.
  • A few studies reported a possible association with gastroschisis (abdominal wall defect), but findings are inconsistent and may reflect confounding.
  • The FDA classifies omeprazole as Pregnancy Category C (animal data show risk, human data limited), but clinical guidelines consider it compatible when benefits outweigh risks.

Clinical Recommendations

  1. Non‑drug measures first: dietary modification, elevation of head of bed, small frequent meals.
  2. If medication needed: omeprazole 20 mg daily is the best‑studied PPI in pregnancy.
  3. Lowest effective dose, shortest duration.
  4. Consult obstetrician/provider before starting or continuing any medication.

Individual Factors

Safety can vary by gestational age, dose, maternal comorbidities, and concomitant medications. Shared decision‑making with a healthcare professional is crucial.

Prescription Medications - Related Articles